http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012076275-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e5c3620d9527ae316d4b275c7847c332
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4794266dc0a9de98eff1a743a5422007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567e3ba8e598f7188b71ecc3862a37d9
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-022
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-14
filingDate 2011-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b5945ef82ba8e05cf73a6cc4f49fff7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0279847617c08c86f320ba5ee0b71a39
publicationDate 2012-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2012076275-A1
titleOfInvention Implant having a paclitaxel-releasing coating
abstract The present invention relates to an implant having a coating or a cavity filling comprising a PLGA polymer and taxane embedded therein, the release rate of the taxane after day two after implantation being ≤ 400 ng/day for a period of more than 10 consecutive days, characterized in that the PLGA polymer has a ratio of monomer units to each other of 60- 99% lactic acid units to 40-1% glycolic acid units.
priorityDate 2010-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006198869-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007224244-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102007004589-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005102222-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010076544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102006038235-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135808554
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID148124
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396419
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396057
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64780
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129159660
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396417
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54277830
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID36314

Total number of triples: 42.